Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001041062-25-000057
Filing Date
2025-02-14
Accepted
2025-02-14 12:53:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8255
  Complete submission text file 0001041062-25-000057.txt   10392
Mailing Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037 8587550239
BRANDES INVESTMENT PARTNERS, LP (Filed by) CIK: 0001015079 (see all company filings)

EIN.: 330704072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88114 | Film No.: 25625918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)